Dr James Black, CRUK Clinical Research Fellow at UCL Cancer Institute, discusses the development of the NeXT Personal ctDNA assay and explains results from an analysis of the TRACERx study, in which the assay was used to show its potential for pre-operative disease stratification in early stage lung cancer.